Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06725173 · ClinicalTrials.gov registry record
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
A clinical trial of Retinoblastoma and Retinoblastoma Bilateral, sponsored by University of Washington.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06725173 is a study of Retinoblastoma and Retinoblastoma Bilateral that is actively recruiting participants, run by University of Washington. The registered enrollment target is 100 participants, below the 586-participant average among 15 other Retinoblastoma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06725173, a study of Retinoblastoma and Retinoblastoma Bilateral, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin for valuable insight into the genotype-phenotype relationship of this cancer syndrome.
Conditions Studied
Interventions
- GENETIC Targeted Long-read sequencing
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2031-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06725173
The ClinicalTrials.gov registry entry for NCT06725173 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 586-participant average among 15 other Retinoblastoma trials with a reported enrollment target (83% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Retinoblastoma appearing as the primary indexed condition, and to 1 intervention - of which Targeted Long-read sequencing is the first listed.
NCT06725173 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06725173 about?
NCT06725173 is a clinical study titled "Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.". The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin...
What is the current status of trial NCT06725173?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-03-16. Estimated completion is 2031-01-01.
What conditions does trial NCT06725173 study?
This clinical trial studies the following conditions: Retinoblastoma, Retinoblastoma Bilateral, Retinoblastoma Unilateral, Retinoblastoma, Extraocular, Retinoblastoma, Recurrent.
What interventions are being tested in trial NCT06725173?
The interventions under investigation include: Targeted Long-read sequencing (GENETIC).
Who is sponsoring clinical trial NCT06725173?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06725173 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinoblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RB Liquid Biopsy Biorepository
RECRUITING
-
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
RECRUITING · Phase 1
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RECRUITING
-
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
RECRUITING
-
Retinoblastoma Phase II Expanded Access Clinical Trial
RECRUITING · Phase 2
-
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.